Endosomal Phosphoinositides and Human Diseases
2008

Endosomal Phosphoinositides and Human Diseases

publication Evidence: moderate

Author Information

Author(s): Nicot Anne-Sophie, Laporte Jocelyn

Primary Institution: Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM U596, CNRS UMR 7104, Université Louis Pasteur de Strasbourg, Collège de France

Hypothesis

The study hypothesizes that defects in endosomal phosphoinositides (PIs) may lead to various human diseases through abnormal membrane remodeling.

Conclusion

The review suggests that mutations in enzymes regulating endosomal PIs are linked to several human genetic diseases, indicating a common pathological mechanism.

Supporting Evidence

  • Mutations in the myotubularin gene are linked to X-linked centronuclear myopathy.
  • PIP5K3 mutations are associated with François–Neetens corneal fleck dystrophy.
  • SAC3/FIG4 mutations are implicated in Charcot–Marie–Tooth peripheral neuropathies.

Takeaway

This study talks about special fats in our cells that help with communication and transport, and how problems with these fats can lead to diseases.

Methodology

The review summarizes various studies on the roles of endosomal PIs and their regulators in human diseases.

Limitations

The review does not provide new experimental data but synthesizes existing literature.

Digital Object Identifier (DOI)

10.1111/j.1600-0854.2008.00754.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication